Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Marizomib, a proteasome inhibitor for all seasons: preclinical profile and a framework for clinical trials.

Marizomib, a proteasome inhibitor for all seasons: preclinical profile and a framework for clinical trials. Curr Cancer Drug Targets. 2011 Mar; 11(3):254-84.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.